What is the recommended treatment for trichomoniasis (trichomonas infection) in pregnancy and how is it contracted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis in Pregnancy

Recommended Treatment Regimen

Pregnant women with trichomoniasis should be treated with metronidazole 2 g orally as a single dose after the first trimester. 1, 2

Critical Timing Considerations

  • Metronidazole is contraindicated during the first trimester of pregnancy due to concerns about fetal organogenesis, as the drug crosses the placental barrier rapidly and its effects on early fetal development are not fully known. 1, 2, 3

  • Treatment after the first trimester is warranted because trichomoniasis is associated with serious adverse pregnancy outcomes including premature rupture of membranes and preterm delivery. 1, 2, 4

First Trimester Management

  • If a pregnant woman presents with symptomatic trichomoniasis during the first trimester, treatment must be delayed until the second trimester begins. 1

  • The evidence does not support effective alternative therapies during the first trimester—topical preparations like clotrimazole have poor efficacy (approximately 50% cure rate) and are not recommended. 5, 6

Dosing Rationale in Pregnancy

  • The single 2 g dose is specifically recommended for pregnant women rather than the 7-day regimen to minimize total fetal drug exposure. 1, 2

  • This approach balances the need to treat the infection (preventing preterm birth) against minimizing medication exposure to the developing fetus. 1, 4

Partner Treatment is Mandatory

  • All sexual partners must be treated simultaneously with the same metronidazole regimen, regardless of symptoms, as most infected men are asymptomatic. 7, 8, 2

  • Patients must abstain from sexual intercourse until both partners complete treatment and are asymptomatic to prevent reinfection. 7, 8, 2

  • Failure to treat partners is the most common cause of treatment failure and reinfection. 8

Critical Patient Counseling

  • Patients must avoid all alcohol during treatment and for at least 24 hours after the last dose to prevent severe disulfiram-like reactions. 7, 8

  • Common side effects include nausea (23%), headache (7%), and vomiting (4%), but these are generally mild to moderate. 9


How Trichomoniasis is Contracted

Transmission Mechanism

Trichomoniasis is contracted through sexual contact with an infected partner. 1

Key Epidemiologic Features

  • Trichomonas vaginalis is a sexually transmitted protozoan that causes the most common non-viral sexually transmitted infection worldwide. 1, 4, 9

  • Most infected men are asymptomatic carriers, making them unknowing vectors of transmission to female partners. 1, 7

  • Among women, the majority develop symptoms including diffuse, malodorous yellow-green vaginal discharge with vulvar irritation, though some women have minimal symptoms. 1

Clinical Implications

  • The asymptomatic nature of infection in men explains why partner treatment is essential even without confirmed testing—untreated partners will reinfect treated patients. 7, 8

  • This is a reportable sexually transmitted infection that requires evaluation and treatment of all recent sexual contacts. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Research

Current therapy of vulvovaginitis.

Sexually transmitted diseases, 1981

Guideline

Treatment of Trichomonas Urethritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trichomoniasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.